SecSonar.com

ClearPoint Neuro, Inc. (CLPT)

ClearPoint Neuro, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

ClearPoint Neuro, Inc. (CLPT) is a Medical - Devices company based in US with a market capitalization of $368.9M. Revenue grew 17.8% year-over-year and free cash flow was negative at -$24.4M. This page tracks CLPT's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 115 employees · IPO May 22, 2012

Valuation

Valuation & price

$11.64 · as of May 17, 2026 · -60.7% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

13.16

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$29.60$19.14$8.68Jul 25Dec 25Jun 26Jul 7, 25$11.80Jul 9, 25$12.25Jul 11, 25$11.40Jul 15, 25$11.15Jul 17, 25$11.38Jul 21, 25$10.98Jul 23, 25$11.58Jul 25, 25$11.23Jul 29, 25$10.55Jul 31, 25$10.40Aug 4, 25$10.53Aug 6, 25$10.79Aug 8, 25$10.82Aug 12, 25$10.54Aug 14, 25$11.68Aug 19, 25$10.46Aug 21, 25$10.24Aug 25, 25$10.50Aug 27, 25$10.64Aug 29, 25$10.49Sep 3, 25$10.25Sep 5, 25$11.05Sep 9, 25$10.95Sep 11, 25$11.09Sep 15, 25$10.47Sep 17, 25$10.66Sep 19, 25$11.20Sep 23, 25$12.16Sep 25, 25$19.74Sep 29, 25$21.57Oct 2, 25$25.05Oct 6, 25$26.59Oct 8, 25$29.60Oct 10, 25$26.11Oct 14, 25$26.03Oct 16, 25$25.28Oct 20, 25$27.32Oct 22, 25$24.29Oct 24, 25$24.74Oct 28, 25$26.98Oct 30, 25$23.68Nov 3, 25$19.00Nov 5, 25$16.98Nov 7, 25$15.81Nov 11, 25$17.40Nov 14, 25$15.43Nov 18, 25$14.30Nov 20, 25$13.51Nov 24, 25$14.40Nov 26, 25$14.44Dec 1, 25$13.74Dec 3, 25$14.08Dec 5, 25$13.54Dec 9, 25$13.43Dec 11, 25$12.97Dec 15, 25$12.38Dec 17, 25$13.56Dec 19, 25$14.20Dec 23, 25$14.37Dec 26, 25$14.02Dec 31, 25$13.68Jan 5, 26$14.19Jan 7, 26$15.29Jan 9, 26$14.92Jan 13, 26$14.47Jan 15, 26$14.65Jan 20, 26$13.90Jan 22, 26$14.21Jan 26, 26$14.20Jan 28, 26$13.43Jan 30, 26$12.93Feb 3, 26$13.94Feb 5, 26$12.57Feb 9, 26$14.11Feb 11, 26$13.37Feb 17, 26$13.58Feb 19, 26$14.35Feb 23, 26$14.76Feb 25, 26$15.16Feb 27, 26$12.57Mar 3, 26$8.84Mar 5, 26$9.25Mar 9, 26$11.54Mar 11, 26$11.62Mar 13, 26$10.79Mar 17, 26$11.16Mar 19, 26$9.18Mar 23, 26$9.51Mar 25, 26$9.49Mar 27, 26$9.07Apr 1, 26$9.14Apr 6, 26$9.38Apr 8, 26$9.17Apr 10, 26$8.68Apr 14, 26$10.38Apr 16, 26$10.50Apr 20, 26$11.16Apr 22, 26$10.99Apr 24, 26$11.78Apr 28, 26$11.08Apr 30, 26$11.18May 4, 26$11.18May 6, 26$11.47May 8, 26$12.82May 12, 26$12.64May 15, 26$11.64May 19, 26$11.17May 21, 26$11.70May 26, 26$11.82May 28, 26$12.24Jun 1, 26$12.64Jun 3, 26$13.30Jun 5, 26$12.89Jun 9, 26$13.59Jun 11, 26$13.84Jun 15, 26$13.52Jun 17, 26$16.81Jun 22, 26$17.06Jun 24, 26$17.98Jun 30, 26$19.11
$8.6652-week range$29.60
Loading valuation history…

Fundamentals

Key fundamentals

$368.9M

Market cap

17.8%

Revenue growth (YoY)

61.4%

Gross margin

-$24.4M

Free cash flow (USD)

$12.3M

Net debt

4.8%

Share dilution

0/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$5.7MFY 2017$7.4MFY 2018$7.4MFY 2019$11.2MFY 2020$12.8MFY 2021$16.3MFY 2022$20.6MFY 2023$24.0MFY 2024$31.4MFY 2025$37.0M
$5.7M$37M

Free cash flow by year

2016 → 2025

FY 2016$-5.9MFY 2017$-6.0MFY 2018$-4.7MFY 2019$-3.0MFY 2020$-8.3MFY 2021$-12.9MFY 2022$-16.4MFY 2023$-14.4MFY 2024$-9.2MFY 2025$-24.4M
-$5.9M-$24.4M

Gross margin by year

2021 → 2025

FY 202168.2%FY 202265.8%FY 202356.8%FY 202460.9%FY 202561.4%
68.2%61.4%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

5

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 13, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • Insider sellInsider Sell $388K · 10b5-1 PlanBURNETT JOSEPH · Director, CEO and President · $387.6KJul 1, 2026Filing
  • Insider sellInsider Sell $1.1M · 10b5-1 PlanBURNETT JOSEPH · Director, CEO and President · $1.1MJun 22, 2026Filing
  • Insider sellInsider Sell $66KRichards Timothy T. · Director · $65.9KJun 2, 2026Filing
  • Insider sellInsider Sell $185KKlein Matthew B. · Director · $185.4KMay 26, 2026Filing
  • Insider sellInsider Sell $57K · 10b5-1 PlanFALLON LYNNETTE C · Director · $56.7KMay 21, 2026Filing
  • 8-K eventIncentive Compensation Plan UpdateMay 21, 2026Filing
  • 8-K eventEarnings ReleaseMay 13, 2026Filing
  • Quarterly report10-Q FiledMay 13, 2026Filing

Questions

Frequently asked questions

What is ClearPoint Neuro, Inc.'s market cap?

ClearPoint Neuro, Inc. (CLPT) has a market capitalization of $368.9M.

What is CLPT's P/E ratio?

A meaningful P/E ratio is not available for CLPT — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is CLPT's price-to-book (P/B) ratio?

CLPT trades at 13.16 times book value per share.

Are insiders buying CLPT stock?

SEC Form 4 filings show no open-market insider buys at ClearPoint Neuro, Inc. in the last 90 days (5 sells).

Same arena

Related companies in Medical - Devices

DCTH

Delcath Systems, Inc.

$368.9M

VMD

Viemed Healthcare, Inc.

$381.1M

OFIX

Orthofix Medical Inc.

$382.1M

MASS

908 Devices Inc.

$322.7M

ELMD

Electromed, Inc.

$318.5M

AVR

Anteris Technologies Global Corp.

$314.1M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.